These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study. Huang J; Zhang D; Xie F; Lin D J Vet Sci; 2015; 16(2):225-31. PubMed ID: 26124697 [TBL] [Abstract][Full Text] [Related]
25. Reirradiation of canine nasal carcinomas treated with coarsely fractionated radiation protocols: 37 cases. Gieger T; Siegel S; Rosen K; Jackson D; Ware K; Kiselow M; Shiomitsu K J Am Anim Hosp Assoc; 2013; 49(5):318-24. PubMed ID: 23861260 [TBL] [Abstract][Full Text] [Related]
27. Expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) in canine nasal carcinomas. Paciello O; Borzacchiello G; Varricchio E; Papparella S J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):406-10. PubMed ID: 17877580 [TBL] [Abstract][Full Text] [Related]
28. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours. Millanta F; Asproni P; Canale A; Citi S; Poli A Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: no significant correlations with clinicopathological variables and treatment outcomes. Fang FM; Li CF; Chien CY; Rau KM; Huang HY Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):447-55. PubMed ID: 17208308 [TBL] [Abstract][Full Text] [Related]
30. Outcome of definitive fractionated radiation followed by exenteration of the nasal cavity in dogs with sinonasal neoplasia: 16 cases. Bowles K; DeSandre-Robinson D; Kubicek L; Lurie D; Milner R; Boston SE Vet Comp Oncol; 2016 Dec; 14(4):350-360. PubMed ID: 25178539 [TBL] [Abstract][Full Text] [Related]
31. Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas. Fox-Alvarez S; Shiomitsu K; Lejeune AT; Szivek A; Kubicek L Vet Radiol Ultrasound; 2020 May; 61(3):370-378. PubMed ID: 32189433 [TBL] [Abstract][Full Text] [Related]
32. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival. Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549 [TBL] [Abstract][Full Text] [Related]
33. Correlations between expression of epidermal growth factor receptor (EGFR), phosphorylated EGFR, cyclooxygenase-2 and clinicopathological variables and treatment outcomes in nasopharyngeal carcinomas. Huang TL; Li CF; Huang HY; Fang FM Chang Gung Med J; 2010; 33(6):619-27. PubMed ID: 21199607 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR. Kim TJ; Lee YS; Kang JH; Kim YS; Kang CS J Surg Oncol; 2011 Jan; 103(1):46-52. PubMed ID: 21031415 [TBL] [Abstract][Full Text] [Related]
35. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival. Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908 [TBL] [Abstract][Full Text] [Related]
36. [Detection of EGFR and COX-2 expression by immunohistochemical method on a tissue microarray section in lung cancer and biological significance]. Zhu C; Liu J; Wang X Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):107-11. PubMed ID: 20673501 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003). Rassnick KM; Goldkamp CE; Erb HN; Scrivani PV; Njaa BL; Gieger TL; Turek MM; McNiel EA; Proulx DR; Chun R; Mauldin GE; Phillips BS; Kristal O J Am Vet Med Assoc; 2006 Aug; 229(3):401-6. PubMed ID: 16881833 [TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor expression in canine transitional cell carcinoma. Hanazono K; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Iwano H; Uchide T J Vet Med Sci; 2015 Jan; 77(1):1-6. PubMed ID: 25223345 [TBL] [Abstract][Full Text] [Related]
39. Treatment of advanced-stage canine nasal carcinomas with toceranib phosphate: 23 cases (2015-2020). Merino-Gutierrez V; Borrego JF; Puig J; Hernández A; Clemente-Vicario F J Small Anim Pract; 2021 Oct; 62(10):881-885. PubMed ID: 34131916 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2. Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]